COM:ONCTERNAL
Oncternal Therapeutics
- Stock
Last Close
1.16
22/11 21:00
Market Cap
21.66M
Beta: -
Volume Today
22.02K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 51.50K - | 51.50K 0% | ||||||||||
average payables | 1.26M - | 660K 47.51% | 447K 32.27% | 801K 79.19% | 1.91M 138.70% | 2.94M 53.84% | 2.08M 29.46% | 1.01M 51.47% | 1.55M 54.02% | 2.44M 57.19% | 2.03M 16.63% | |
average receivables | 4.50K - | 89K - | 405K 355.06% | |||||||||
book value per share | 11.86 - | 15.26 28.63% | 0.93 93.92% | 9.56 931.54% | 15.36 60.57% | 7.83 49.02% | 1.39 82.30% | -4.08 394.29% | -2.31 43.25% | -3.01 30.07% | 10.22 439.61% | |
capex per share | -0.04 - | -0.00 87.96% | -0.00 53.37% | -0.04 2,069.17% | -0.00 98.14% | |||||||
capex to depreciation | -0.08 - | -0.05 41.18% | -0.09 89.77% | -3.21 3,355.36% | -0.04 98.68% | |||||||
capex to operating cash flow | 0.00 - | 0.00 76.11% | 0.00 14.84% | 0.00 2,069.54% | 0.00 98.03% | |||||||
capex to revenue | 0.04 - | |||||||||||
cash per share | 16.35 - | 42.18 157.97% | 14.59 65.41% | 10.51 27.94% | 17.62 67.57% | 8.53 51.57% | 1.94 77.25% | 5.75 196.16% | 1.84 67.99% | 1.21 34.16% | 11.65 861.63% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 293.86 - | |||||||||||
debt to assets | 0.01 - | 0.00 96.15% | 0.00 138.04% | 0.00 58.13% | 0.00 271.68% | |||||||
debt to equity | 0.01 - | -0.00 103.64% | -0.00 36.02% | -0.00 16.37% | 0.01 1,147.45% | |||||||
dividend yield | ||||||||||||
earnings yield | -0.40 - | -0.66 63.05% | -0.19 71.16% | -0.23 21.12% | -0.14 40.44% | -2.11 1,436.44% | -0.39 81.51% | -0.17 55.65% | -0.28 61.63% | -0.83 195.12% | -1.25 51.82% | |
enterprise value | 89.52M - | 41.84M 53.26% | 84.20M 101.24% | 67.96M 19.28% | 205.86M 202.90% | -10.05M 104.88% | 20.94M 308.39% | -17.20M 182.16% | 21.27M 223.64% | 15.54M 26.94% | 25.14M 61.77% | |
enterprise value over ebitda | -2.05 - | -1.94 5.41% | -3.38 73.97% | -1.99 41.00% | -6.72 236.90% | 0.26 103.84% | -1.41 648.12% | 0.98 169.46% | -0.68 169.15% | -0.35 49.02% | -0.60 74.31% | |
ev to operating cash flow | -2.04 - | -1.45 28.54% | -4.20 188.87% | -3.27 22.17% | -8.78 168.27% | 0.26 102.91% | -1.25 589.62% | 0.98 178.64% | -0.80 181.35% | -0.42 47.07% | -0.78 84.61% | |
ev to sales | -27.07 - | 32.02 - | ||||||||||
free cash flow per share | -48.85 - | -24.61 49.61% | -9.99 59.40% | -10.03 0.40% | -9.42 6.15% | -11.80 25.28% | -1.62 86.26% | -0.86 46.86% | -0.54 37.43% | -0.70 29.45% | -10.94 1,467.64% | |
free cash flow yield | -0.42 - | -0.48 13.89% | -0.20 57.66% | -0.27 33.10% | -0.11 61.01% | -2.16 1,941.49% | -0.41 81.00% | -0.18 57.16% | -0.24 35.06% | -0.70 193.85% | -1.02 46.23% | |
graham net net | 10.89 - | 14.10 29.46% | -0.46 103.24% | 8.30 1,916.37% | 14.42 73.77% | 6.97 51.65% | 1.22 82.47% | 5.46 346.97% | 1.73 68.33% | 1.07 38.19% | 9.54 792.50% | |
graham number | 111.69 - | 107.59 3.67% | 13.95 87.04% | 42.82 206.99% | 64.97 51.72% | 45.05 30.67% | 6.93 84.62% | 8.82 27.24% | 5.75 34.81% | 7.47 30.04% | 55.57 643.46% | |
income quality | 1.04 - | 0.73 30.11% | 1.07 46.80% | 1.17 9.44% | 0.77 34.26% | 1.02 32.88% | 0.49 52.17% | 1.02 107.36% | 0.85 16.45% | 0.83 2.08% | 0.81 1.96% | |
intangibles to total assets | 0.02 - | 0.01 54.93% | 0.00 54.00% | 0.01 17.37% | 0.00 53.47% | 0.00 28.48% | 0 100% | 0 | 0 | 0 | 0 | |
interest coverage | 64.03 - | |||||||||||
interest debt per share | 0.02 - | 0.00 89.29% | 0.00 22.81% | -0.01 868.97% | 0.06 603.22% | |||||||
inventory turnover | ||||||||||||
invested capital | 0.01 - | -0.00 103.64% | -0.00 36.02% | -0.00 16.37% | 0.01 1,147.45% | |||||||
market cap | 104.04M - | 59.72M 42.60% | 98.26M 64.53% | 76.87M 21.76% | 221.68M 188.36% | 18.21M 91.79% | 40.80M 124.05% | 99.49M 143.86% | 111.96M 12.53% | 52.59M 53.02% | 31.52M 40.08% | |
net current asset value | 10.25M - | 17.33M 69.06% | 1.72M 90.09% | 19.69M 1,046.59% | 38.10M 93.54% | 26.00M 31.77% | 13.36M 48.63% | 112.14M 739.72% | 87.39M 22.08% | 59.61M 31.79% | 29.38M 50.71% | |
net debt to ebitda | 0.33 - | 0.83 149.05% | 0.56 32.04% | 0.26 53.67% | 0.52 97.43% | 0.72 40.39% | 1.34 84.87% | 6.65 396.80% | 2.89 56.54% | 0.82 71.49% | 0.15 81.45% | |
net income per share | -46.75 - | -33.72 27.86% | -9.33 72.34% | -8.52 8.64% | -12.22 43.36% | -11.52 5.71% | -1.54 86.63% | -0.85 44.98% | -0.63 25.12% | -0.83 30.01% | -13.43 1,527.55% | |
operating cash flow per share | -48.81 - | -24.61 49.59% | -9.99 59.40% | -9.99 0.02% | -9.42 5.75% | -11.80 25.30% | -1.62 86.26% | -0.86 46.86% | -0.54 37.43% | -0.70 29.45% | -10.94 1,467.64% | |
payables turnover | ||||||||||||
receivables turnover | 1.24 - | |||||||||||
research and ddevelopement to revenue | -6.86 - | 37.90 - | ||||||||||
return on tangible assets | -2.76 - | -0.79 71.50% | -0.59 25.34% | -0.73 23.98% | -0.66 9.23% | -1.23 86.44% | -0.73 40.52% | -0.14 80.21% | -0.33 130.90% | -0.63 88.99% | -1.07 70.05% | |
revenue per share | -1.21 - | 0.27 - | ||||||||||
roe | -3.94 - | -2.21 43.92% | -10.06 355.14% | -0.89 91.14% | -0.80 10.72% | -1.47 84.94% | -1.11 24.44% | 0.21 118.69% | 0.27 31.95% | 0.27 0.05% | -1.31 579.24% | |
roic | -4.04 - | -2.08 48.61% | -9.79 370.95% | -0.70 92.83% | -0.80 14.08% | -1.52 90.11% | -1.05 31.04% | 0.21 120.20% | 0.27 29.75% | 0.28 1.58% | -1.37 591.87% | |
sales general and administrative to revenue | -3.47 - | 16.24 - | ||||||||||
shareholders equity per share | 11.86 - | 15.26 28.63% | 0.93 93.92% | 9.56 931.54% | 15.36 60.57% | 7.83 49.02% | 1.39 82.30% | -4.08 394.29% | -2.31 43.25% | -3.01 30.07% | 10.22 439.61% | |
stock based compensation to revenue | -1.18 - | 9.55 - | ||||||||||
tangible asset value | 10.36M - | 17.36M 67.52% | 1.72M 90.08% | 19.77M 1,047.97% | 38.15M 93.00% | 26.02M 31.81% | 14.31M 44.99% | 112.95M 689.20% | 88.12M 21.98% | 60.97M 30.81% | 30.05M 50.71% | |
tangible book value per share | 11.50 - | 14.85 29.12% | 0.86 94.22% | 9.50 1,006.72% | 15.31 61.11% | 7.80 49.06% | 1.39 82.24% | 5.56 301.46% | 1.79 67.88% | 1.16 35.12% | 10.22 781.77% | |
working capital | 10.60M - | 17.36M 63.70% | 1.72M 90.11% | 19.69M 1,046.59% | 38.10M 93.54% | 26.00M 31.77% | 13.45M 48.28% | 112.14M 734.04% | 87.39M 22.08% | 59.61M 31.79% | 30.86M 48.23% |
All numbers in USD (except ratios and percentages)